Basics Lifecore Biomedical, Inc. IPO Date: March 1, 1996 Sector: Healthcare Industry: Drug Manufacturers - Specialty and Generic Market Cap: $284.72M Activated in VL: True Average Daily Range Avg Daily Range: $0.19 | 3.01% Avg Daily Range (30 D): $0.17 | 2.23% Avg Daily Range (90 D): $0.17 | 2.46% Institutional Daily Volume Avg Daily Volume: .26M Avg Daily Volume (30 D): .12M Avg Daily Volume (90 D): .18M Trade Size Avg Trade Size (Sh.): 92 Avg Trade Size (Sh.) (30 D): 61 Avg Trade Size (Sh.) (90 D): 68 Institutional Trades Total Inst.Trades: 28 Avg Inst. Trade: $2.87M Avg Inst. Trade (30 D): $2.33M Avg Inst. Trade (90 D): $2.79M Avg Inst. Trade Volume: .4M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $5.65M Avg Closing Trade (30 D): $3.28M Avg Closing Trade (90 D): $2.95M Avg Closing Volume: 773.96K     News Jun 17, 2025 @ 11:00 AM Lifecore Biomedical Signs New 10-Year Commercial M... Source: N/A Jun 12, 2025 @ 11:00 AM Lifecore Biomedical Receives Accelerated Payment o... Source: N/A Mar 17, 2025 @ 11:00 AM Humanetics Selects Lifecore Biomedical to Deliver ... Source: N/A Jan 17, 2025 @ 10:24 PM Lifecore Biomedical Announces Special Stockholder ... Source: N/A Jan 7, 2025 @ 2:00 PM Lifecore Biomedical Further Strengthens Financial ... Source: N/A Financials   TTM Q3 2025 Q2 2025 Basic EPS $-1.47 $-.47 $-.25 Diluted EPS $-1.44 $-.47 $-.25 Revenue $ 130.31M $ 35.15M $ 32.56M Gross Profit $ 43.59M $ 9.85M $ 11.08M Net Income / Loss $ -44.65M $ -14.77M $ -6.57M Operating Income / Loss $ -20.42M $ -9.03M $ -1.96M Cost of Revenue $ 86.72M $ 25.31M $ 21.48M Net Cash Flow $ 2.34M $ -4.04M $ 3.94M PE Ratio